[{"AccountsPayableCurrent_0_Q2_USD":5116000.0,"OtherAssetsCurrent_0_Q2_USD":492000.0,"OtherAssetsNoncurrent_0_Q2_USD":31500000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":116000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-602000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-44000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-44000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-1299000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-160000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-697000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":-78000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":-133000.0,"OtherLiabilitiesCurrent_0_Q2_USD":3146000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":4068000.0,"OtherLongTermDebt_0_Q2_USD":12000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":4185000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":2249000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":494000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":282591000.0,"LiabilitiesCurrent_0_Q2_USD":16280000.0,"LongTermDebtCurrent_0_Q2_USD":0.0,"LongTermDebtNoncurrent_0_Q2_USD":141774000.0,"MarketableSecuritiesCurrent_0_Q2_USD":135701000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":149000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":29315000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-33566000.0,"NetIncomeLoss_1_Q2_USD":-19581000.0,"NetIncomeLoss_2_Q2_USD":-33026000.0,"NetIncomeLossAttributableToParentDiluted_1_Q2_USD":-19581000.0,"NetIncomeLossAttributableToParentDiluted_2_Q2_USD":-33026000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OperatingIncomeLoss_1_Q2_USD":-21936000.0,"OperatingIncomeLoss_2_Q2_USD":-36747000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":1589000.0,"Liabilities_0_Q2_USD":163711000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":757000.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":53372000.0,"RestructuringReserveCurrent_0_Q2_USD":177000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-403453000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":0.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":15174000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":26186000.0,"ShareBasedCompensation_2_Q2_USD":3729000.0,"StockholdersEquity_0_Q2_USD":118880000.0,"UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_0_Q2_USD":3143000.0,"ValueAddedTaxReceivableCurrent_0_Q2_USD":306000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q2_shares":0.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_2_Q2_shares":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":58488000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":58465000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":58488000.0,"RestructuringCharges_2_Q2_USD":-53000.0,"PaymentsForRoyalties_2_Q2_USD":0.0,"RestructuringCharges_1_Q2_USD":0.0,"ResearchAndDevelopmentExpense_1_Q2_USD":6762000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":26000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"PreferredStockSharesAuthorized_0_Q2_shares":50000000.0,"PreferredStockSharesIssued_0_Q2_shares":488000.0,"PreferredStockSharesOutstanding_0_Q2_shares":488000.0,"PreferredStockValue_0_Q2_USD":5000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":25308000.0,"PrepaidExpenseCurrent_0_Q2_USD":3983000.0,"ProceedsFromDivestitureOfBusinesses_2_Q2_USD":16500000.0,"ProceedsFromIncomeTaxRefunds_2_Q2_USD":3078000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":0.0,"ProceedsFromIssuanceOfPrivatePlacement_2_Q2_USD":0.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":149000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":66213000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":321000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":10614000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":58465000.0,"InvestmentIncomeNet_2_Q2_USD":1042000.0,"InterestPaidNet_2_Q2_USD":3234000.0,"CapitalizedContractCostNet_0_Q2_USD":0.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":67142000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":67142000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-4580000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockSharesAuthorized_0_Q2_shares":500000000.0,"CommonStockSharesIssued_0_Q2_shares":58488000.0,"CommonStockSharesOutstanding_0_Q2_shares":58488000.0,"CommonStockValue_0_Q2_USD":584000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-19625000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-34325000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":0.0,"CostOfGoodsAndServicesSold_2_Q2_USD":0.0,"CostsAndExpenses_1_Q2_USD":21936000.0,"CostsAndExpenses_2_Q2_USD":36747000.0,"BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized_0_Q2_USD":0.0,"DebtSecuritiesAvailableForSaleRealizedGain_1_Q2_USD":41000.0,"BusinessCombinationAcquisitionRelatedCosts_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":135701000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":7524000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-22350000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":544094000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":2001000.0,"AmortizationOfFinancingCostsAndDiscounts_1_Q2_USD":313000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":625000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":0.0,"AmortizationOfIntangibleAssets_2_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":15586.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":15426.0,"Assets_0_Q2_USD":282591000.0,"AssetsCurrent_0_Q2_USD":230702000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1486000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":473000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":134688000.0,"BusinessCombinationAcquisitionRelatedCosts_1_Q2_USD":0.0,"InvestmentIncomeNet_1_Q2_USD":432000.0,"DebtSecuritiesAvailableForSaleRealizedGain_2_Q2_USD":52000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_2_Q2_USD":107000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-23346000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-39398000.0,"IncomeTaxesPaidNet_2_Q2_USD":7000.0,"IncomeTaxesReceivable_0_Q2_USD":18835000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-3765000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-6372000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":176000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":0.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":1199000.0,"IncreaseDecreaseInAccruedTaxesPayable_2_Q2_USD":0.0,"IncreaseDecreaseInInventories_2_Q2_USD":0.0,"IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_2_Q2_USD":1021000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":3106000.0,"InterestExpenseDebt_1_Q2_USD":1930000.0,"InterestExpenseDebt_2_Q2_USD":3859000.0,"GuarantyLiabilities_0_Q2_USD":913000.0,"DebtSecuritiesAvailableForSaleRealizedLoss_1_Q2_USD":39000.0,"GuaranteeObligationsCurrentCarryingValue_0_Q2_USD":1188000.0,"GainLossOnSaleOfBusiness_2_Q2_USD":0.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-6228000.0,"DeferredTaxAssetsNet_0_Q2_USD":24484000.0,"DepositsAssetsCurrent_0_Q2_USD":1418000.0,"DepreciationAndAmortization_2_Q2_USD":417000.0,"DilutiveSecurities_1_Q2_USD":0.0,"DilutiveSecurities_2_Q2_USD":0.0,"DueToAffiliateCurrent_0_Q2_USD":0.0,"EarningsPerShareBasic_1_Q2_USD":-0.33,"EarningsPerShareBasic_2_Q2_USD":-0.56,"EarningsPerShareDiluted_1_Q2_USD":-0.33,"EarningsPerShareDiluted_2_Q2_USD":-0.56,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.161,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.162,"EffectOfExchangeRateOnCashAndCashEquivalents_2_Q2_USD":-478000.0,"GainLossOnSaleOfBusiness_1_Q2_USD":0.0,"Goodwill_0_Q2_USD":16836000.0,"WorkersCompensationLiabilityCurrent_0_Q2_USD":1504000.0,"Ticker":"AVDL","CIK":"1012477","name":"AVADEL PHARMACEUTICALS PLC","OfficialName":"Avadel Pharmaceuticals plc American Depositary Shares","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"391383731.0","Country":"France","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]